GYRE
Gyre Therapeutics, Inc. Common Stock
$5.93
0.08%
+0.00
Notify me if price changes either direction
Buy GYRE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
573.4M
Enterprise value
526.7M
Trailing PE
364.5
Forward PE
98.5
PEG Ratio
-0.84115384615385
Enterprise to EBITDA
103.824
Enterprise to revenue
4.5
Price to book MRQ
5.3291254
Price to sales TTM
4.899122
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
117.0M
EBITDA
11.3M
Diluted EPS TTM
-0.08
Total Cash (MRQ)
49.8M
Current ratio (MRQ)
4.636
Operating Cash Flow (TTM)
4.3M
GYRE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
